Table 6.
Multiple linear regression analysis for RDW and HOMA-β in LADA patients in total and subgroups
| B | SE | β | t | P | ||
|---|---|---|---|---|---|---|
| Total | RDW (Model 1) | 0.012 | 0.003 | 0.152 | 3.542 | 0.007 |
| RDW (Model 2) | 0.012 | 0.003 | 0.137 | 2.985 | 0.009 | |
| RDW (Model 3) | 0.012 | 0.003 | 0.115 | 2.047 | 0.032 | |
| LADA-1 | RDW (Model 1) | 0.007 | 0.001 | 0.098 | 1.524 | 0.069 |
| RDW (Model 2) | 0.007 | 0.001 | 0.087 | 1.412 | 0.078 | |
| RDW (Model 3) | 0.007 | 0.001 | 0.065 | 1.291 | 0.103 | |
| LADA-2 | RDW (Model 1) | 0.016 | 0.004 | 0.204 | 3.774 | 0.006 |
| RDW (Model 2) | 0.016 | 0.004 | 0.186 | 3.042 | 0.009 | |
| RDW (Model 3) | 0.016 | 0.004 | 0.173 | 2.654 | 0.017 |
Model1: unadjusted; Model 2: adjusted for age, BMI, sex and diabetes duration; Model3: adjusted for age, BMI, sex, diabetes duration and HbA1c;